Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2022-04-27 00:00:00 ET · period of report 2022-04-25 · accession 0000899243-22-015762 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-04-27 | 2022-04-25 | VRTX | Ambrose Kristen | SVP, CAO | S - Sale | $269.55 | -327 | 3,600 | -8% | -$88.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-25 | S | D | 104 | $271.68 | 3,496 | D | — | — | (F6) Open market sales reported on this line occurred at a weighted average price of $271.68 (range $271.25 to $272.23). (F2) Ms. Ambrose undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2022-04-25 | S | D | 80 | $268.46 | 3,683 | D | — | — | (F4) Open market sales reported on this line occurred at a weighted average price of $268.46 (range $268.05 to $268.86). (F2) Ms. Ambrose undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2022-04-25 | S | D | 60 | $267.37 | 3,763 | D | — | — | (F3) Open market sales reported on this line occurred at a weighted average price of $267.37 (range $266.86 to $267.85). (F2) Ms. Ambrose undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2022-04-25 | S | D | 83 | $269.51 | 3,600 | D | — | — | (F2) Ms. Ambrose undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F5) Open market sales reported on this line occurred at a weighted average price of $269.51 (range $269.12 to $269.90). |